Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial

(2013) G Nasti et al.   BRITISH JOURNAL OF CANCER

Morbidity of Surgery After Neoadjuvant Chemotherapy Including Bevacizumab for Advanced Ovarian Cancer

(2013) Elisabeth Chéreau et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignancies

(2013) Ingmar Königsrainer et al.   LANGENBECKS ARCHIVES OF SURGERY

Progression Following Neoadjuvant Systemic Chemotherapy May Not Be a Contraindication to a Curative Approach for Colorectal Carcinomatosis

(2012) Guillaume Passot et al.   ANNALS OF SURGERY

Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy

(2012) Y.L.B. Klaver et al.   EJSO

Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: A matched-pair analysis

(2012) Gabriel Glockzin et al.   JOURNAL OF SURGICAL ONCOLOGY

Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases

(2012) Anne E.M. van der Pool et al.   JOURNAL OF SURGICAL ONCOLOGY

A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C

(2012) Konstantinos Votanopoulos et al.   JOURNAL OF SURGICAL RESEARCH

Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?

(2012) Paul H Sugarbaker et al.   LANCET ONCOLOGY

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

(2011) Samar Masoumi Moghaddam et al.   CANCER AND METASTASIS REVIEWS

Biologic therapies in the metastatic colorectal cancer treatment continuum – Applying current evidence to clinical practice

(2011) Marc Peeters et al.   CANCER TREATMENT REVIEWS

Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O.

(2010) F. Cavaliere et al.   EJSO

Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study

(2010) Valery E. Lemmens et al.   INTERNATIONAL JOURNAL OF CANCER

Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy

(2010) Yvonne L.B. Klaver et al.   JOURNAL OF SURGICAL ONCOLOGY

Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study

(2009) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases

(2008) Susan B. Kesmodel et al.   JOURNAL OF CLINICAL ONCOLOGY